Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Hereditary α-tryptasemia is associated with anaphylaxis to antibiotics and monoclonal antibodies
Authors:ID Korošec, Peter, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Author)
ID Lyons, Jonathan J. (Author)
ID Svetina, Manca, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Author)
ID Koudová, Monika (Author)
ID Bittóová, Martina (Author)
ID Zidarn, Mihaela, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Author)
ID Sedláčková, Lenka (Author)
ID Rijavec, Matija, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Author)
ID Kopač, Peter, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Author)
Files:URL URL - Source URL, visit https://www.sciencedirect.com/science/article/pii/S2213219825003691
 
.pdf PDF - Presentation file, download (733,20 KB)
MD5: CD374FFE205E3F910EF21E81088A3AE6
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKPBAG - University Clinic of Respiratory and Allergic Diseases Golnik
Abstract:Background Hereditary α-tryptasemia, a genetic trait caused by increased α-tryptase copy number, is associated with idiopathic and venom anaphylaxis. Objective We aimed to determine the impact of tryptase genotypes on drug-induced anaphylaxis. Methods A prospective discovery cohort of 99 patients from a referral center in Slovenia with acute anaphylaxis to drugs underwent tryptase genotyping by droplet digital PCR. For validation, we included a cohort of 26 patients from the Czech Republic. Associated inciting agents and the severity of the reactions were subsequently examined. Results Hereditary α-tryptasemia was associated with drug-induced anaphylaxis with a prevalence of 13% (n = 13 of 99) in the discovery cohort and 15% in the validation cohort (n = 4 of 26). Hereditary α-tryptasemia was identified in every individual with elevated basal serum tryptase levels (11.6-21.9 ng/mL; n = 14) within both cohorts of patients. Hereditary α-tryptasemia was more prevalent in individuals with antibiotic- or mAb-induced anaphylaxis in both the discovery and validation cohorts (n = 13 of 51; 26%) compared to those with anaphylaxis resulting from neuromuscular blocking agents, nonsteroidal anti-inflammatory drugs, contrast, chlorhexidine, or other drugs (n = 5 of 74; 7%; P = .02; odds ratio = 4.1; 95% CI, 1.3-11.1). Overall, we found fewer individuals with no ⍺-tryptase than in the general population, and there was a trend for subjects with more ⍺-tryptase copies to have more severe reactions. Thus, among subjects with three ⍺-tryptase copies, the prevalence of severe anaphylaxis was 73%, compared with 59% with one to two ⍺-tryptase copies and 58% for subjects without ⍺-tryptase. Conclusions Risk for anaphylaxis to antibiotics and biologics is associated with inherited differences in α-tryptase–encoding copies at Tryptase α/β1 .
Keywords:immunology, drug allergy, anaphylaxis, antibiotics, monoclonal antibodies, α-tryptase, hereditary α-tryptasemia
Publication status:Published
Publication version:Version of Record
Submitted for review:02.10.2024
Article acceptance date:07.04.2025
Publication date:17.04.2025
Publisher:Elsevier, 2013-
Year of publishing:2025
Number of pages:str. 1449-1456.e4
Numbering:Vol. 13, iss. 6
Source:The journal of allergy and clinical immunology. In practice
PID:20.500.12556/DiRROS-22721 New window
UDC:616-097
ISSN on article:2213-2201
DOI:10.1016/j.jaip.2025.04.013 New window
COBISS.SI-ID:233461507 New window
Copyright:© 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Note:Nasl. z nasl. zaslona; Opis vira z dne 22. 4. 2025;
Publication date in DiRROS:18.06.2025
Views:471
Downloads:254
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:The journal of allergy and clinical immunology : In practice
Publisher:Elsevier
ISSN:2213-2201
COBISS.SI-ID:2048298353 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0360
Name:Celostna obravnava alergijskih bolezni in astme v Sloveniji: od epidemiologije do genetike

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-3072
Name:Dedni dejavniki anafilaksije povezani s povečanim številom α-triptaza kodirajoče sekvence TPSAB1

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:17.04.2025
Applies to:Version of Record valid from 2025-04-17

Secondary language

Language:Slovenian
Keywords:imunologija, alergije, antibiotiki, dednost, monoklonska protitelesa


Back